Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 243

1.

In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.

Capone A, Cafiso V, Campanile F, Parisi G, Mariani B, Petrosillo N, Stefani S.

Eur J Clin Microbiol Infect Dis. 2016 Jan 27. [Epub ahead of print]

PMID:
26815434
2.

Infective endocarditis in patients with hepatic diseases.

Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, Castelli F, Bassetti M, Barbaro F, Grossi P, Barzaghi N, Rizzi M, Minoli L.

Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):279-84. doi: 10.1007/s10096-015-2541-4. Epub 2015 Dec 21.

PMID:
26690071
3.

Criteria for discharge of patients with Ebola virus diseases in high-income countries.

Bevilacqua N, Nicastri E, Chinello P, Puro V, Petrosillo N, Caro AD, Capobianchi MR, Lanini S, Vairo F, Pletschette M, Zumla A, Ippolito G; INMI Ebola Team.

Lancet Glob Health. 2015 Oct 21. pii: S2214-109X(15)00205-3. doi: 10.1016/S2214-109X(15)00205-3. [Epub ahead of print] No abstract available.

4.

Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy.

Frustaci A, Ciccosanti F, Chimenti C, Nardacci R, Corazzari M, Verardo R, Ippolito G, Petrosillo N, Fimia GM, Piacentini M.

Int J Cardiol. 2016 Jan 15;203:282-9. doi: 10.1016/j.ijcard.2015.10.119. Epub 2015 Oct 20.

PMID:
26519687
5.

First Italian Ebola virus disease case: management of hospital internal and external communication.

Salce L, Barbato S, Renna D, Bianchini F, Vaccaro P, Mazzeo F, Gasparini A, Rizza C, Lanfranchi E, Petrosillo N, Nicastri E, Di Caro A, Capobianchi MR, Puro V, Ippolito G; INMI EBOV Team.

New Microbiol. 2015 Oct;38(4):565-70. Epub 2015 Oct 20.

6.

Ebola virus disease complicated with viral interstitial pneumonia: a case report.

Petrosillo N, Nicastri E, Lanini S, Capobianchi MR, Di Caro A, Antonini M, Puro V, Lauria FN, Shindo N, Magrini N, Kobinger GP, Ippolito G; INMI EBOV Team.

BMC Infect Dis. 2015 Oct 16;15:432. doi: 10.1186/s12879-015-1169-4.

7.

The Protective Role of Albumin in Clostridium difficile Infection: A Step Toward Solving the Puzzle.

Di Bella S, di Masi A, Turla S, Ascenzi P, Gouliouris T, Petrosillo N.

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1478-80. doi: 10.1017/ice.2015.221. Epub 2015 Oct 12. No abstract available.

PMID:
26456662
8.

Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M.

Intensive Care Med. 2015 Dec;41(12):2057-75. doi: 10.1007/s00134-015-4079-4. Epub 2015 Oct 5.

PMID:
26438224
9.

Consensus statement: patient safety, healthcare-associated infections and hospital environmental surfaces.

Roques C, Al Mousa H, Duse A, Gallagher R, Koburger T, Lingaas E, Petrosillo N, Škrlin J.

Future Microbiol. 2015;10(10):1629-34. doi: 10.2217/fmb.15.85. Epub 2015 Oct 6.

PMID:
26437762
10.

Disinfection of personal protective equipment for management of Ebola patients.

Puro V, Pittalis S, Chinello P, Nicastri E, Petrosillo N, Antonini M, Ippolito G; Ebola INMI Task Force.

Am J Infect Control. 2015 Dec 1;43(12):1375-6. doi: 10.1016/j.ajic.2015.07.040. Epub 2015 Sep 26. No abstract available.

PMID:
26409916
11.

WSES guidelines for management of Clostridium difficile infection in surgical patients.

Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GA, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P.

World J Emerg Surg. 2015 Aug 20;10:38. doi: 10.1186/s13017-015-0033-6. eCollection 2015. Review.

12.

Comment on: "Diagnosis of Periprosthetic Joint Infection: The Role of Nuclear Medicine May Be Overestimated" by Claudio Diaz-Ledezma, Courtney Lamberton, Paul Lichtstein and Javad Parvizi.

Glaudemans AW, Jutte PC, Petrosillo N, Erba PA, Lazzeri E, Signore A.

J Arthroplasty. 2016 Feb;31(2):551-2. doi: 10.1016/j.arth.2015.07.002. Epub 2015 Jul 10. No abstract available.

PMID:
26253477
13.

Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE).

Guleri A, Utili R, Dohmen P, Petrosillo N, Piper C, Pathan R, Hamed K.

Infect Dis Ther. 2015 Sep;4(3):283-96. doi: 10.1007/s40121-015-0075-9. Epub 2015 Jul 14.

14.

Molecular Characterization of the First Ebola Virus Isolated in Italy, from a Health Care Worker Repatriated from Sierra Leone.

Castilletti C, Carletti F, Gruber CE, Bordi L, Lalle E, Quartu S, Meschi S, Lapa D, Colavita F, Chiappini R, Mazzarelli A, Marsella P, Petrosillo N, Nicastri E, Chillemi G, Valentini A, Desideri A, Di Caro A, Ippolito G, Capobianchi MR.

Genome Announc. 2015 Jun 18;3(3). pii: e00639-15. doi: 10.1128/genomeA.00639-15.

15.

Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.

Pea F, Petrosillo N, Garau J.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):927-37. doi: 10.1586/14787210.2015.1056159. Epub 2015 Jun 11.

PMID:
26065544
16.

Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.

Falasca L, Agrati C, Petrosillo N, Di Caro A, Capobianchi MR, Ippolito G, Piacentini M.

Cell Death Differ. 2015 Aug;22(8):1250-9. doi: 10.1038/cdd.2015.67. Epub 2015 May 29. Review.

17.

The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.

Asensio A, Di Bella S, Lo Vecchio A, Grau S, Hart WM, Isidoro B, Scotto R, Petrosillo N, Watt M, Nazir J.

Int J Infect Dis. 2015 Jul;36:31-8. doi: 10.1016/j.ijid.2015.05.013. Epub 2015 May 21.

18.

Is tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature.

Di Bella S, Nisii C, Petrosillo N.

Int J Antimicrob Agents. 2015 Jul;46(1):8-12. doi: 10.1016/j.ijantimicag.2015.03.012. Epub 2015 May 1. Review.

PMID:
25982915
19.

Radiographic imaging in Ebola Virus Disease: protocol to acquire chest radiographs.

Busi Rizzi E, Puro V, Schinina' V, Nicastri E, Petrosillo N, Ippolito G.

Eur Radiol. 2015 Nov;25(11):3368-71. doi: 10.1007/s00330-015-3748-6. Epub 2015 Apr 23.

PMID:
25903713
20.

Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).

Di Bella S, Friedrich AW, García-Almodóvar E, Gallone MS, Taglietti F, Topino S, Galati V, Johnson E, D'Arezzo S, Petrosillo N.

BMC Infect Dis. 2015 Apr 22;15:194. doi: 10.1186/s12879-015-0932-x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk